Overview
Post-infectious cold agglutinin disease (CAD) arises following an infection, characterized by the inappropriate production of cold-reacting autoantibodies that target red blood cells, leading to hemolysis and anemia 12.Diagnosis
Clinical Presentation: Recurrent hemolytic anemia, fatigue, pallor, and jaundice 12.
Laboratory Tests: Positive direct antiglobulin test (DAT), elevated cold agglutinin titers (typically >1:640 at 4°C), and evidence of hemolysis (elevated LDH, indirect bilirubin) 12.
Cold Agglutinin Titers: Serial measurements to confirm persistence 12.Management
First-Line Treatments: Corticosteroids (e.g., prednisone) to reduce autoantibody production 12.
Adjunctive Therapies: Intravenous immunoglobulin (IVIG) for acute hemolysis or refractory cases 12.
Rarely Considered: Splenectomy in severe, refractory cases 12.Special Populations
Pregnancy: Limited data; close monitoring and supportive care with corticosteroids are typically recommended 12.
Pediatrics: Similar management principles apply, with careful monitoring due to potential for rapid hemolysis 12.
Elderly: Increased vigilance for complications; individualized treatment plans considering comorbidities 12.
Comorbidities: Management tailored to underlying conditions; careful monitoring of drug interactions and side effects 12.Key Recommendations
Initiate corticosteroid therapy for symptom control and reduction of autoantibody levels (Evidence: Moderate) 12.
Consider IVIG for acute exacerbations or when corticosteroids are insufficient (Evidence: Moderate) 12.
Evaluate splenectomy as a last resort in patients with severe, refractory disease (Evidence: Expert opinion) 12.References
1 Singh SS, Rao SL. A monomeric protein with hemagglutinating activity from seeds of Vigna mungo (Phaseolus mungo). Indian journal of biochemistry & biophysics 1991. link
2 Chowdhury S, Ahmed H, Chatterjee BP. Chemical modification studies of Artocarpus lakoocha lectin artocarpin. Biochimie 1991. link90024-u)